SANTOLLA, Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 1.349
EU - Europa 868
AS - Asia 336
AF - Africa 61
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.619
Nazione #
US - Stati Uniti d'America 1.327
UA - Ucraina 261
DE - Germania 171
IT - Italia 142
CN - Cina 136
SG - Singapore 121
AT - Austria 118
SE - Svezia 74
SN - Senegal 60
FI - Finlandia 49
TR - Turchia 35
CA - Canada 19
BE - Belgio 14
CZ - Repubblica Ceca 13
HK - Hong Kong 13
IN - India 13
KR - Corea 13
GB - Regno Unito 8
NL - Olanda 8
FR - Francia 6
AU - Australia 3
CH - Svizzera 3
EU - Europa 2
CR - Costa Rica 1
IE - Irlanda 1
JM - Giamaica 1
JP - Giappone 1
MX - Messico 1
PH - Filippine 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 2.619
Città #
Chandler 255
Jacksonville 150
San Mateo 102
Boardman 87
Vienna 86
Singapore 85
Ashburn 83
Dearborn 79
New York 78
Dakar 60
Helsinki 47
Rende 45
Florence 35
Lawrence 34
Roxbury 34
Izmir 30
Shanghai 30
Brooklyn 25
Munich 23
Des Moines 22
Ann Arbor 21
Seattle 17
Ottawa 15
Brussels 14
Beijing 13
Brno 13
Seoul 13
Ogden 11
Redmond 11
Bremen 10
Falkenstein 10
Hong Kong 10
Wilmington 9
San Francisco 8
Inglewood 7
Wuhan 7
Cambridge 6
Guangzhou 6
Bari 5
Como 5
Redwood City 5
Edinburgh 4
Grafing 4
Nanjing 4
Berlin 3
Jiaxing 3
Jinan 3
Los Angeles 3
Mascalucia 3
Portoferraio 3
Toronto 3
Amsterdam 2
Boydton 2
Central 2
Changsha 2
Chennai 2
Espoo 2
Gazi 2
Geneve 2
Haikou 2
Heze 2
Houston 2
Kunming 2
Messina 2
Paternò 2
Quanzhou 2
Roggiano Gravina 2
Tappahannock 2
Yiwu 2
Canberra 1
Cirò Marina 1
Dalian 1
Dublin 1
Esslingen am Neckar 1
Frankfurt am Main 1
Handan 1
Hangzhou 1
Hebei 1
Hefei 1
Huzhou 1
Innsbruck 1
Jinhua 1
Johannesburg 1
Kilburn 1
Lanzhou 1
Lodi 1
Longyan 1
Manila 1
Melbourne 1
Miami 1
Montalto Uffugo 1
Mountain View 1
Napoli 1
Norwalk 1
Osaka 1
Padova 1
Palermo 1
Paris 1
Puebla 1
Pune 1
Totale 1.706
Nome #
(6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells 136
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 117
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 117
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 114
Estrogenic GPER signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (CAFs) 105
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts 104
Carbazole derivatives as potential novel agonist of GPER 99
Apoptosis of breast cancer cells induced by lauric acid occours through p21Cip/WAF1 in a p53 independent manner 98
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models. 91
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 91
BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma 90
Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts 87
Identification of novel estrogen-regulated microRNAs in breast tumor cells and cancer-associated fibroblasts (CAFS) 83
Estrogenic Gper-signaling triggers RERG expression in breast cancer cells and cancer-associated fibroblasts 79
GPER mediates activation of HIF1α/VEGF signaling by estrogens 77
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 77
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 77
G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts 76
Nuovi ligandi di recettori estrogenici accoppiati a proteina G 74
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 74
S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells 72
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 67
MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells 65
Recent Advances in the Rationale Design of GPER Ligands. 64
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells. 58
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 58
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 55
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 54
Insulin-like growth factor-I regulates GPER expression and function in cancer cells 51
Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands. 49
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 46
Novel Mechanisms Involved in the Stimulatory Effects Exerted by Zinc in Breast Cancer Cells 44
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 44
The FGF/FGFR system in breast cancer: Oncogenic features and therapeutic perspectives 39
Oleuropein-induced apoptosis is mediated by mitochondrial glyoxalase 2 in NSCLC a549 cells: A mechanistic inside and a possible novel nonenzymatic role for an ancient enzyme 36
Totale 2.668
Categoria #
all - tutte 16.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020141 0 0 0 0 0 0 28 45 18 6 34 10
2020/2021283 38 3 37 35 3 32 9 41 27 29 2 27
2021/2022452 4 76 0 33 52 5 6 117 1 4 56 98
2022/2023648 80 102 29 86 76 49 2 76 61 11 51 25
2023/2024488 59 26 26 12 19 97 16 80 34 24 10 85
2024/2025296 38 80 28 62 24 47 17 0 0 0 0 0
Totale 2.668